I just saw a really smart lady on Bloomberg & she said what i was saying. Biden's tax plan would be very bad maybe 15% of GDP if enacted right away. If spread out over three years it's like 3%. Very Important Joe spreads this tax hike out-- VAN you have the only stk going up today!
WPX Energy Inc ">WPX Energy Inc WPX Energy Inc (NYSE:WPX), a Tulsa, Oklahoma-based independent explorer and producer of oil and natural gas. WPX Energy Inc's price-to-tangible-book-value ratio of 0.57 appeals more than the industry median of 0.86. As of Oct. 14, the stock price was $4.77 per share, while the tangible book value per share was $8.37. The stock has declined by 51.5% over the past year for a market capitalization of $2.68 billion and a 52-week range of $1.94 to $14.43. Suncor Energy Inc">Suncor Energy Inc Suncor Energy Inc (NYSE:SU), a Canadian petroleum and gas integrated operator. Suncor Energy Inc's price-to-tangible-book-value ratio of 0.74 is more appealing than the industry median of 0.86. As of Oct. 14, the stock price traded at $12.37 per share, while the tangible book value per share was $16.72. The stock price performance was quite disappointing for the shareholders over the past 52 weeks as it slumped 58.6%, determining a market capitalization of $18.85 billion and a 52-week range of $9.61 to $34.56.
Today was supposed to be the last day of swimming in the pool. It is a beautiful day. I let the propane run out. I'm so pissed. All that leaf skimming for what? - There's a message about the market in there somewhere. I took a brief look at some holdings and would note that I too have some up names not just VAN... those of you who followed me into STC, ALLY, BERY & TAST are noting incredible RS-- They are all up! BOXL too! I have not bought yet....
SIFY to the moon! opened today at $1.20. Earnings report tomorrow morning. "Sify Technologies Limited is an Indian information and communications technology company providing end to end ICT solutions including telecom services, data center services, cloud & managed services, transformation integration services and application integration services. Wikipedia"
Ya know what Stoney... I do remember that "glue" call-out you had lol, now that you mention it. I'm gonna do a search... h/o EDIT: I couldn't find it, but I swear I remember you posted about that company. Or maybe it was JJ that told me about it. Someone did. Hey in the search I found this gem... What is it with you and the damn rodents?
Van we remodeled the whole kitchen just before the pandemic. Sealed all the holes and put down flooring and new cabinets (custom) best thing we ever did. Not only did we stop the baby mice but we stopped the giant water bugs which had adapted in our apt and had started to fly! Life in the big city as they say.... Not much in thh way of news today: Carrier Global initiated with an Overweight at Stephens 16:11 CARR Stephens analyst Tommy Moll initiated coverage of Carrier Global with an Overweight rating and Street-high $45 price target. The analyst is making a "high conviction" call on the shares based on an absolute and relative basis versus the company's heating, ventilation, and air conditioning peers. Moll believes the "pure play" has "meaningful" self-help opportunities on both the top line. Amazing recovery by AMRN. These guys have been around forever with their fish oil.. really, fish oil and they took a big hit this year recently the stk crashed but instead of going to zero... first one analyst said they thought they could save their drug in the US and now they have apparently used the drug on an entirely new problem... Our goes depression in comes something else. And it works! This is one of the best bio saves ever. Back in 1998-- Three Wound-Healing Products OKed By FDA Panel 05-02-1998 RELATED COMPANIES Novartis Legend Biotech Johnson & Johnson The General and Plastic Surgery Devices Advisory Committee hasrecommended that the US Food and Drug Administration approve two artificial skin products, Organogenesis/Novartis' Apligraf and Advanced Tissue Sciences/Smith & Nephew's Dermagraft. It also voted to recommend approval of Closure Medical's surgical glue, DermaBond. >> Apligraf is the glue but Closure Med seemed to have a beter product. I probably jumped from ORGo to Closure...<< The panel voted 5-4 that the FDA should approve Apligraf human skin equivalent for the treatment of venous leg ulcers, a condition which affects about one million people in the USA alone. Another problem-->It is manufactured in vitro from cells taken from discarded foreskins of newborn circumcisions, <- Not that's there anything wrong with that.reports the Associated Press, and remains alive for five days before implantation. The company says that the product has now been used in more than 400 patients without rejection. Novartis is also conducting clinical trials of Apligraf in skin surgery wounds and in burns. I believe Novartis took it from there... Finally, the FDA panel has also unanimously recommended approval of Closure Medical Corps' DermaBond (made from octylcyanoacrylate) for use in skin-deep cuts or for minimally invasive surgery.
Usually when giant bottoms come in to play-- a news article will signify it.... " everyone has given up on stocks " or something like that... in this case: ‘Our return sucks over the past few years…and we’ve just run out of time,’ says $10 billion value investor calling it quits
Wall Street won’t have Ted Aronson to kick around anymore. After a punishing stretch for the investment fund that he helped start nearly four decades ago, AJO Partners, with offices in Philadelphia and Boston, is calling it quits. Aronson put the reasoning behind the planned closure of the $10 billion investment manager at the end of the year simply and unabashedly in an interview with MarketWatch on Thursday afternoon: “Our return sucks over the past few years.” Pulling no punches, he added: “Our shit is so bad it’s unbelievable compared to our peers.” > > > > U.S. Cannabis Readies for the Elections 2020 could mark the end of our modern-day prohibition FACEBOOK TWITTER LINKEDIN ByTODD A. HARRISON Updated Oct 15, 2020 [Todd Harrison is the CIO and co-founder of CB1 Capital and a columnist for Investopedia. The views expressed herein are those of the author and do not necessarily reflect the views of Investopedia.] 2020 will be remembered for many things but for the U.S. cannabis industry, it’ll be remembered as the beginning. While the grassroots seeded a few seasons ago, history, with the benefit of hindsight, will point to the economic motivation stemming from the pandemic1 and this year’s social justice movement as the beginning of the end of our modern-day prohibition. The first half of the year helped shape theFANGification of U.S cannabisbut the landscape remains uneven at best and rife with risks. Much of that has to do with the federal treatment of cannabis and the complex regulatory framework that U.S. operators are forced to endure. And while somebarbarians have slipped through the gates, most institutional investors remain on the outside looking in. After a steady rise off the March lows, U.S. cannabis stocks retreated in September for several reasons: most were technically overbought, and the specter of a bipartisan agreement on stimulus dimmed with the passing of U.S. Supreme Court Justice Ruth Bader Ginsburg. That helped dash hopes that theSAFE Banking Actprovisions in the House version of the stimulus bill would pass the Senate, which cooled sentiment surrounding the space. Marijuana Laws by State The upcoming elections will further shape the operating landscape. States have been scrambling for tax-revenue and their constituents need jobs; legal cannabis drives both at scale. New Jersey, Arizona, Mississippi, Montana and South Dakota will vote on cannabis referenda and we believe New Jersey will pass adult-use, which should trigger2 New York, Pennsylvania, Connecticut and Rhode Island to do the same. While further state adoption will increase the total addressable market, the federal elections offer a pathway to structural reform. A blue Senate would remove the chokehold on long-overdue legislation that protects states’ rights and allows for SAFE banking, debt financing and a lower cost of capital. A blue sweep would add steroids that could help fast-track institutional participation and U.S. exchange listings. Cowen Research recently shared a nifty visual on U.S. cannabis election probabilities that offers a fair assessment. From a flow of funds perspective, should we see a blue wave, U.S. hedge funds would be first movers (we saw this buying begin in early October) followed by family offices and off-shore investors, and then large U.S. institutions likely once legislation becomes law, presumably around this time next year. Cowen Research. Should the GOP maintain the status quo, it could further bifurcate the industry chasm between the haves and have-nots. The half-dozen or so U.S. cannabis companies generating positive cash flow and positioned to achieve operating efficiencies at scale would gain share while the rest of the industry awaits a tenable federal solution and clarity around the timing of SAFE banking and access to capital markets. Business is Good The U.S. cannabis landscape is going to look a lot different in a few weeks. Whether that’s the addition of several states or a seismic shift that democratizes the space remains to be seen. And while we agree this industry maybe the truest, bluest bet on the board, we don’t view the election as a referendum on survival as much as a variable that will help shape the forward trajectory. Value investorBenjamin Grahamonce observed that, “in the short-run, the market is a voting machine but in the long-run, the market is a weighing machine.” Those words ring true with an election looming and fast money circling, but the truth is, big money investors aren’t fixated on the outcome as much as they’re focused on the fundamental growth that will continue to scale. Recent channel checks with industry leaders and a review of tax receipts suggest business is trending ahead of estimates. While those stateside fundamentals are the primary difference between cannabis 1.0 (Canadian cultivation) and cannabis 2.0 (U.S-led CPG), most investors still don’t know the difference between Cronos and Curaleaf. That disconnect, and the nascency of the industry at large, presents tremendous opportunities for those willing to do the work. YCharts. A snapshot of select U.S. cannabis operators helps frame this discussion. Leaving aside the electoral optionality and allowing for existing regulatory and tax impediments, companies that are executing against their plan stand to benefit regardless of what happens at the federal level. As JW Asset Management President Jason Wild recently noted in Barron’s3 , “you’re not going to find growth like this anywhere else at these multiples.” CB1 Capital Mgmt. The road ahead promises to be bumpy, as frontier markets tend to be; and then there is the issue of the broader market, one that is hinged to the specter of never-ending stimuli; the potential for a contested election or civil unrest; and an absence of clarity around the duration of the virus or the timeline for a vaccine or therapeutic response that will allow for a return to normalcy. We don’t profess to know the answers to those questions but we’re relatively confident that over time, intelligent investors will buy legitimate growth at reasonable multiples; and we’re further assured by the sense that so few investors are seemingly aware that cannabis is an asset class, much less one that is in the throes of a secular bull market. In November 2012,I tweeted, “Prohibition ended with the Great Depression and modern prohibition (cannabis) will end with our generation’s Great Depression.” The equity rally of 2020 may have masked the economic upheaval driven by the novel coronavirus, but the state budget shortfalls and structural unemployment suggest that while history doesn’t always repeat, it will likely rhyme.
CURL- continues to look good. I am opposed to their making of flavored vapes. This is a moral problem and this is why I got in trouble last time with the Pot stocks-- I can't remove my own feelings-- Organic pure no chemicals and no vaping.